- Home
- TOWN vs MRUS Comparison
TOWN vs MRUS Comparison
Compare TOWN & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOWN
- MRUS
- Stock Information
- Founded
- TOWN 1998
- MRUS 2003
- Country
- TOWN United States
- MRUS Netherlands
- Employees
- TOWN N/A
- MRUS N/A
- Industry
- TOWN Major Banks
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- TOWN Finance
- MRUS Health Care
- Exchange
- TOWN Nasdaq
- MRUS Nasdaq
- Market Cap
- TOWN 2.5B
- MRUS 2.9B
- IPO Year
- TOWN 1999
- MRUS 2016
- Fundamental
- Price
- TOWN $34.51
- MRUS $39.74
- Analyst Decision
- TOWN Buy
- MRUS Strong Buy
- Analyst Count
- TOWN 1
- MRUS 12
- Target Price
- TOWN $40.00
- MRUS $87.92
- AVG Volume (30 Days)
- TOWN 225.6K
- MRUS 658.9K
- Earning Date
- TOWN 02-04-2025
- MRUS 02-26-2025
- Dividend Yield
- TOWN 2.90%
- MRUS N/A
- EPS Growth
- TOWN N/A
- MRUS N/A
- EPS
- TOWN 1.99
- MRUS N/A
- Revenue
- TOWN $671,844,000.00
- MRUS $35,932,000.00
- Revenue This Year
- TOWN N/A
- MRUS N/A
- Revenue Next Year
- TOWN $13.81
- MRUS $57.49
- P/E Ratio
- TOWN $17.30
- MRUS N/A
- Revenue Growth
- TOWN N/A
- MRUS N/A
- 52 Week Low
- TOWN $25.70
- MRUS $33.60
- 52 Week High
- TOWN $38.28
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- TOWN 52.22
- MRUS 39.51
- Support Level
- TOWN $33.63
- MRUS $38.52
- Resistance Level
- TOWN $34.74
- MRUS $47.75
- Average True Range (ATR)
- TOWN 0.77
- MRUS 2.02
- MACD
- TOWN 0.16
- MRUS -0.14
- Stochastic Oscillator
- TOWN 87.07
- MRUS 19.74
About TOWN TowneBank
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and Insurance Segment provides provide a wide array of insurance products, including property, casualty, life, and health insurance.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.